AGP Executive Report
Last update: 6 hours agoUS–Liechtenstein Pharma Trade: The US Commerce Department has listed Liechtenstein (along with 19 other jurisdictions) for a 0% ad valorem tariff on select specialty medicines and key ingredients, even as a broader 100% tariff on certain patented drugs starts for other companies from 29 September; the zero-duty categories include orphan drugs, infertility treatments, cell and gene therapies, antibody-drug conjugates, and some medical countermeasures, with eligibility tied to specific trade/security frameworks. EU Digital Identity: After 20 years, the .eu domain is framed as everyday European infrastructure, with the choice of a European top-level domain seen as a signal of community rather than a technical upgrade. Market Watch (Furniture): Europe’s upholstered furniture sector remains highly fragmented, with concentration slowly rising and Liechtenstein-based Cotta Collection among the notable manufacturers by market share. Cross-border Trade (EFTA–India): India and EFTA will review the TEPA trade pact at a summit in October, aiming to tackle market-access and procedural bottlenecks as exports to the bloc have fallen. Local/Regional Context: A separate report notes relaxed staffing rules in healthcare to ease shortages, relevant for services and workforce planning.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.